Autoimmune Diseases
Welcome,         Profile    Billing    Logout  
 293 Companies   490 Products   490 Products   199 Mechanisms of Action   25 Trials   7787 News 


«12...4748495051525354555657...156157»
  • ||||||||||  arsenic trioxide / Generic mfg.
    P2a data, Trial termination, Trial primary completion date:  Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC) (clinicaltrials.gov) -  Jan 6, 2016   
    P2,  N=11, Terminated, 
    Recruiting --> Completed Recruiting --> Terminated | Trial primary completion date: Jan 2016 --> Oct 2015; Difficulty of inclusions and a sufficient number of relevant clinical information
  • ||||||||||  Trial completion, Trial initiation date, Trial primary completion date:  DIADEME: Effect of Sleep Apnea Treatment on Type 1 Diabetes (clinicaltrials.gov) -  Jan 6, 2016   
    P=N/A,  N=81, Completed, 
    Recruiting --> Terminated | Trial primary completion date: Jan 2016 --> Oct 2015; Difficulty of inclusions and a sufficient number of relevant clinical information Recruiting --> Completed | Initiation date: Jan 2014 --> Apr 2013 | Trial primary completion date: Dec 2015 --> Oct 2014
  • ||||||||||  Enrollment closed, Enrollment change:  Telecare in Type 1 Diabetes (T1D) Patients Treated by Insulin Pump (clinicaltrials.gov) -  Jan 5, 2016   
    P=N/A,  N=66, Active, not recruiting, 
    Recruiting --> Completed | Initiation date: Jan 2014 --> Apr 2013 | Trial primary completion date: Dec 2015 --> Oct 2014 Recruiting --> Active, not recruiting | N=120 --> 66
  • ||||||||||  dimethyl fumarate / Generic mfg.
    New trial:  Tecfidera and MRI for Brain Energy in MS (clinicaltrials.gov) -  Dec 31, 2015   
    P=N/A,  N=21, Not yet recruiting, 
  • ||||||||||  Phase classification, Trial primary completion date:  Remission Induction and Sustenance in Graves' Disease 2 (clinicaltrials.gov) -  Dec 31, 2015   
    P=N/A,  N=250, Active, not recruiting, 
    Active, not recruiting --> Completed Phase classification: P4 --> P=N/A | Trial primary completion date: Oct 2015 --> Oct 2017
  • ||||||||||  Trial completion, Trial primary completion date:  Pancreatic Duct Evaluation in Autoimmune Pancreatitis: MR Pancreatography (clinicaltrials.gov) -  Dec 30, 2015   
    P=N/A,  N=30, Completed, 
    Phase classification: P4 --> P=N/A | Trial primary completion date: Oct 2015 --> Oct 2017 Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Mar 2015
  • ||||||||||  Enrollment closed:  Evolution of Effectiveness of Diabetes Medical Care in Russia (clinicaltrials.gov) -  Dec 30, 2015   
    P=N/A,  N=600, Active, not recruiting, 
    Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Mar 2015 Recruiting --> Active, not recruiting
  • ||||||||||  Trial primary completion date:  Honey in Chronic Immune Thrombocytopenia (clinicaltrials.gov) -  Dec 29, 2015   
    P2,  N=30, Suspended, 
    Trial primary completion date: Sep 2015 --> Apr 2016 Trial primary completion date: Nov 2014 --> Jan 2016
  • ||||||||||  Orencia (abatacept) / BMS
    Trial completion, Enrollment change, Trial primary completion date:  Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis (clinicaltrials.gov) -  Dec 25, 2015   
    P2,  N=98, Completed, 
    Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=66 --> 98 | Trial primary completion date: May 2015 --> Aug 2015
  • ||||||||||  Trial completion, Trial primary completion date:  CLEAR: Registry for African Americans With Early Rheumatoid Arthritis (clinicaltrials.gov) -  Dec 25, 2015   
    P=N/A,  N=357, Completed, 
    Active, not recruiting --> Completed | N=66 --> 98 | Trial primary completion date: May 2015 --> Aug 2015 Active, not recruiting --> Completed | Trial primary completion date: Sep 2006 --> Dec 2011
  • ||||||||||  Enrollment change, Trial primary completion date:  An ACT Based Application for Young People With Type 1 Diabetes (clinicaltrials.gov) -  Dec 24, 2015   
    P=N/A,  N=33, Terminated, 
    Active, not recruiting --> Completed | Trial primary completion date: Sep 2006 --> Dec 2011 N=116 --> 33 | Trial primary completion date: Nov 2015 --> Apr 2016
  • ||||||||||  tibulizumab (ZB-106) / Zura Bio
    Enrollment open:  A Study of LY3090106 in Participants With Sj (clinicaltrials.gov) -  Dec 24, 2015   
    P1,  N=32, Recruiting, 
    N=116 --> 33 | Trial primary completion date: Nov 2015 --> Apr 2016 Not yet recruiting --> Recruiting
  • ||||||||||  Trial primary completion date, IO biomarker:  Auto-HTAP: Auto-immunity and Pulmonary Arterial Hypertension (clinicaltrials.gov) -  Dec 23, 2015   
    P=N/A,  N=629, Active, not recruiting, 
    Trial primary completion date: Jul 2016 --> Sep 2015 Trial primary completion date: Sep 2015 --> Mar 2016
  • ||||||||||  Trial completion, Enrollment change:  Is a Diet Necessary When Corticosteroid Treatment is Prescribed? (clinicaltrials.gov) -  Dec 23, 2015   
    P=N/A,  N=50, Completed, 
    Trial primary completion date: Sep 2015 --> Mar 2016 Active, not recruiting --> Completed | N=170 --> 50
  • ||||||||||  DegludecPlus (insulin degludec/insulin aspart) / Novo Nordisk
    Enrollment open:  Post Marketing Surveillance (PMS) Study of Ryzodeg (clinicaltrials.gov) -  Dec 18, 2015   
    P=N/A,  N=1000, Enrolling by invitation, 
    N=40 --> 27 Not yet recruiting --> Enrolling by invitation